CFM
CNMD icon

Catalyst Funds Management’s CONMED CNMD Stock Holding History

Catalyst Funds Management’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-300
Closed -$21.6K – 524
2024
Q3 		$21.6K Sell
300
-100
-25% -$7.06K ﹤0.01% 1064
2024
Q2 		$27.7K Buy
+400
New +$29.2K 0.01% 578

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Catalyst Funds Management's CNMD Position: Q4 2024 in Review

Catalyst Funds Management sold out of CONMED (CNMD) in Q4 2024, closing a stake of 300 shares — an estimated $21.6K sold.

Catalyst Funds Management first reported a position in CNMD in Q2 2024 and held it in 2 quarters. The position peaked at $27.7K in Q2 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q4 2024.

  • Catalyst Funds Management reported no remaining CONMED position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 300 CONMED shares in Q4 2024, an estimated $21.6K.
  • Catalyst Funds Management first reported a position in CONMED in Q2 2024 and held it in 2 quarters.
  • Catalyst Funds Management's CONMED position peaked at $27.7K in Q2 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.